Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 56

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 56
---
1,421 thousand for the same period.

Comparison of Predecessor’s Results of Operations for the year ended December 31, 2023 and 2022

The following table is data derived from the Consolidated Statement of Operations (in thousands) and the discussions that follow are in approximate amounts:

|                                     |     | For the year ended 
 December, 31       |  2023 |   |     |     | 2022 |   |
|:------------------------------------|:----|:-------------------|------:|:--|:----|:----|-----:|:--|
|                                     |     | USD in thousands   |       |   |     |     |      |   |
| Research and development expenses   |     |                    |   846 |   |     |     |  324 |   |
| General and administrative expenses |     |                    |   156 |   |     |     |  112 |   |
| Operating loss                      |     |                    | 1,002 |   |     |     |  436 |   |
| Financial income, net               |     |                    |   (15 | ) |     |     |    * | ) |
| Loss for the period                 |     |                    |   987 |   |     |     |  436 |   |

| *) | less            
 than 1 thousand |

Research and Development Expenses

Predecessor’s research and development expenses totaled $846 thousand for the year ended December 31, 2023, representing an increase of $522 thousand, or 161.1%, compared to $324 thousand for the year ended December 31, 2022. The increase was primarily attributable to the increase in salaries to our employees, increase in share-based payment expenses and increase in fees paid to our consultants and service providers following expansion of our research and development agreement with Yissum.

General and Administrative Expenses

Predecessor’s general and administrative expenses totaled $156 thousand for the year ended December 31, 2023, representing an increase of $44 thousand, or 39.3%, compared to $112 thousand for the year ended December 31, 2022. The increase was primarily attributable to an increase in professional services expenses.

<div align='center'>35</div>

Operating Loss

As a result of the foregoing, Predecessor’s operating loss totaled $1,002 thousand for the year ended December 31, 2023, representing an increase of